Andrew L. Ji

Andrew L. Ji

Auto-generated profile, based on publicly available information

Andrew L. Ji

Department of Dermatology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2021 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
SLSophia K. Longo
Sophia K. Longo
MGMargaret G. Guo
Margaret G. Guo
AJAndrew L. Ji
Andrew L. Ji
PKPaul A. Khavari
Paul A. Khavari

10 August 2022 in Nature
Verified
Journal Article
Open access
PDF file
AEAndrew Erickson
Andrew Erickson
MHMengxiao He
Mengxiao He
EBEmelie Berglund
Emelie Berglund
MMMaja Marklund
Maja Marklund
RMReza Mirzazadeh
Reza Mirzazadeh
JLJoakim Lundeberg
Joakim Lundeberg
Defining the transition from benign to malignant tissue is fundamental to improving early diagnosis of cancer1. Here we use a systematic approach to study spatial genome integrity in situ and describe previously unidentified clonal relationships. We used spatially resolved transcriptomics2 to infer spatial copy number variations in >120,000 regions across multiple organs, in benign and malignant tissues. We demonstrate that genome-wide copy number variation reveals distinct clonal patterns within tumours and in nearby benign tissue using an organ-wide approach focused on the prostate. Our results suggest a model for how genomic instability arises in histologically benign tissue that may represent early events in cancer evolution. We highlight the power of capturing the molecular and spatial continuums in a tissue context and challenge the rationale for treatment paradigms, including focal therapy.

29 November 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LBLudvig Bergenstråhle
Ludvig Bergenstråhle
BHBryan He
Bryan He
JBJoseph Bergenstråhle
Joseph Bergenstråhle
XAXesús Abalo
Xesús Abalo
RMReza Mirzazadeh
Reza Mirzazadeh
JMJonas Maaskola
Jonas Maaskola

10 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
DPDouglas F. Porter
Douglas F. Porter
WMWeili Miao
Weili Miao
XYXue Yang
Xue Yang
GGGrant A. Goda
Grant A. Goda
AJAndrew L. Ji
Andrew L. Ji
PKPaul A. Khavari
Paul A. Khavari
Quantitative criteria to identify proteins as RNA-binding proteins (RBPs) are presently lacking, as are criteria to define RBP target RNAs. Here, we develop an ultraviolet (UV) cross-linking immunoprecipitation (CLIP)-sequencing method, easyCLIP. easyCLIP provides absolute cross-link rates, as well as increased simplicity, efficiency, and capacity to visualize RNA libraries during sequencing library preparation. Measurement of >200 independent cross-link experiments across >35 proteins identifies an RNA cross-link rate threshold that distinguishes RBPs from non-RBPs and defines target RNAs as those with a complex frequency unlikely for a random protein. We apply easyCLIP to the 33 most recurrent cancer mutations across 28 RBPs, finding increased RNA binding per RBP molecule for KHDRBS2 R168C, A1CF E34K and PCBP1 L100P/Q cancer mutations. Quantitating RBP-RNA interactions can thus nominate proteins as RBPs and define the impact of specific disease-associated RBP mutations on RNA association.

21 March 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
APArianna J. Piñeiro
Arianna J. Piñeiro
AHAubrey E. Houser
Aubrey E. Houser
AJAndrew L. Ji
Andrew L. Ji

2 May 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KTKim Thrane
Kim Thrane
MWMårten C.G. Winge
Mårten C.G. Winge
HWHongyu Wang
Hongyu Wang
LCLarry Chen
Larry Chen
MGMargaret G. Guo
Margaret G. Guo
AJAndrew L. Ji
Andrew L. Ji